Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer.
Ochi K, Suzawa K, Tomida S, Shien K, Takano J, Miyauchi S, Takeda T, Miura A, Araki K, Nakata K, Yamamoto H, Okazaki M, Sugimoto S, Shien T, Yamane M, Azuma K, Okamoto Y, Toyooka S.
Ochi K, et al. Among authors: okamoto y.
Biochem Biophys Res Commun. 2020 Aug 27;529(3):760-765. doi: 10.1016/j.bbrc.2020.06.077. Epub 2020 Jul 19.
Biochem Biophys Res Commun. 2020.
PMID: 32736704
Free article.